Repayment of new medicine development subsidy, requested to be reduced

Published: 2001-04-24 06:59:00

Updated: 2001-04-24 06:59:00

Korea Pharmaceutical Manufacturers Association (KPMA) decided to request the Ministry of Health and Welfare to improve the system related to the redemption of new medicine development subsidy. It will be asking the MOHW to reduce the amount to repay to 50% of the amount supported and also arrang...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK